CH605833A5 - - Google Patents

Info

Publication number
CH605833A5
CH605833A5 CH1358675A CH1358675A CH605833A5 CH 605833 A5 CH605833 A5 CH 605833A5 CH 1358675 A CH1358675 A CH 1358675A CH 1358675 A CH1358675 A CH 1358675A CH 605833 A5 CH605833 A5 CH 605833A5
Authority
CH
Switzerland
Application number
CH1358675A
Inventor
Antonio Alcaide Garcia
Juan Ramon Conde Ruiz
Juan Bermejo Lozano
Original Assignee
Liade Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liade Sa Lab filed Critical Liade Sa Lab
Publication of CH605833A5 publication Critical patent/CH605833A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
CH1358675A 1974-11-27 1975-10-20 CH605833A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES432334A ES432334A1 (es) 1974-11-27 1974-11-27 Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.

Publications (1)

Publication Number Publication Date
CH605833A5 true CH605833A5 (xx) 1978-10-13

Family

ID=8468076

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1358675A CH605833A5 (xx) 1974-11-27 1975-10-20

Country Status (5)

Country Link
JP (1) JPS5165778A (xx)
CH (1) CH605833A5 (xx)
DE (1) DE2545329A1 (xx)
ES (1) ES432334A1 (xx)
FR (1) FR2292477A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56157809U (xx) * 1980-04-24 1981-11-25
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533241A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
AU691829B2 (en) * 1993-07-16 1998-05-28 Merck & Co., Inc. Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
AU675730B2 (en) * 1993-07-16 1997-02-13 Merck & Co., Inc. Substituted piperazinylcamphor derivatives as oxytocin antagonists
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
KR20010025140A (ko) * 2000-02-11 2001-04-06 남홍길 보르네올 또는 캄포를 유효성분으로 하는 니코틴 수용체길항제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES374515A1 (es) * 1969-12-12 1972-01-01 Liade Sa Lab Procedimiento de obtencion de nuevos compuestos con accio- nes cardiovasculares.

Also Published As

Publication number Publication date
FR2292477B1 (xx) 1979-09-14
DE2545329A1 (de) 1976-08-12
JPS5165778A (en) 1976-06-07
FR2292477A1 (fr) 1976-06-25
JPS541317B2 (xx) 1979-01-23
ES432334A1 (es) 1976-11-01

Similar Documents

Publication Publication Date Title
FR2268774B1 (xx)
JPS5134913A (xx)
FR2292477B1 (xx)
FR2280274B1 (xx)
FR2268037A1 (xx)
JPS5121788U (xx)
FR2292301B3 (xx)
FI751958A (xx)
FR2275939B1 (xx)
JPS50126748U (xx)
JPS5143119U (xx)
HU168950B (xx)
JPS50104865U (xx)
JPS50107017U (xx)
CH1736574A4 (xx)
CH580804A5 (xx)
CH571823A5 (xx)
CH596183A5 (xx)
CH568649A5 (xx)
CH567761A5 (xx)
CH565950A5 (xx)
CH561141A5 (xx)
CH582817A5 (xx)
CH1378974A4 (xx)
CH576625A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased